3/2
09:04 am
txg
10x Genomics (TXG) had its price target raised by Stifel Nicolaus from $20.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
10x Genomics (TXG) had its price target raised by Stifel Nicolaus from $20.00 to $25.00. They now have a "buy" rating on the stock.
2/20
07:04 am
txg
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/19
04:05 pm
txg
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
Low
Report
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
2/13
10:16 am
txg
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at TD Cowen.
Medium
Report
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at TD Cowen.
2/13
10:14 am
txg
10x Genomics (NASDAQ:TXG) was given a new $17.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "hold" rating on the stock.
Medium
Report
10x Genomics (NASDAQ:TXG) was given a new $17.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "hold" rating on the stock.
2/13
09:09 am
txg
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Stifel Nicolaus.
Low
Report
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Stifel Nicolaus.
2/13
09:09 am
txg
10x Genomics (NASDAQ:TXG) was given a new $22.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
10x Genomics (NASDAQ:TXG) was given a new $22.00 price target on by analysts at Canaccord Genuity Group Inc..
2/13
12:35 am
txg
10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations Amid ... [Yahoo! Finance]
Low
Report
10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations Amid ... [Yahoo! Finance]
2/12
05:11 pm
txg
10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 [Yahoo! Finance]
Low
Report
10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 [Yahoo! Finance]
2/12
04:05 pm
txg
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
Medium
Report
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
2/4
09:00 am
txg
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
Low
Report
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
2/3
04:47 am
txg
1 Momentum Stock to Target This Week and 2 We Turn Down [Yahoo! Finance]
Low
Report
1 Momentum Stock to Target This Week and 2 We Turn Down [Yahoo! Finance]
1/27
02:29 pm
txg
10x Genomics (NASDAQ:TXG) had its price target lowered by analysts at Leerink Partners from $22.00 to $20.00. They now have a "market perform" rating on the stock.
Low
Report
10x Genomics (NASDAQ:TXG) had its price target lowered by analysts at Leerink Partners from $22.00 to $20.00. They now have a "market perform" rating on the stock.
1/22
04:05 pm
txg
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
Medium
Report
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
1/19
06:52 am
txg
3 Hyped Up Stocks That Concern Us [Yahoo! Finance]
Low
Report
3 Hyped Up Stocks That Concern Us [Yahoo! Finance]
1/12
09:26 am
txg
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease [Yahoo! Finance]
Medium
Report
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease [Yahoo! Finance]
1/12
09:11 am
txg
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
Medium
Report
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
1/12
09:10 am
txg
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
Medium
Report
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
1/12
09:00 am
txg
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
Medium
Report
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
1/12
08:42 am
txg
10x Genomics (NASDAQ:TXG) was given a new $21.00 price target on by analysts at Needham & Company LLC.
Medium
Report
10x Genomics (NASDAQ:TXG) was given a new $21.00 price target on by analysts at Needham & Company LLC.
1/11
12:00 pm
txg
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
Medium
Report
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
1/7
01:18 pm
txg
10x Genomics (NASDAQ:TXG) had its price target raised by analysts at TD Cowen from $15.00 to $18.00. They now have a "hold" rating on the stock.
Low
Report
10x Genomics (NASDAQ:TXG) had its price target raised by analysts at TD Cowen from $15.00 to $18.00. They now have a "hold" rating on the stock.
1/7
10:58 am
txg
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at Cowen Inc.
Low
Report
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at Cowen Inc.
1/2
07:01 pm
txg
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid [Yahoo! Finance]
High
Report
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid [Yahoo! Finance]
12/29
04:05 pm
txg
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference